tpo agents beyond itp
Published 4 years ago • 612 plays • Length 27:49Download video MP4
Download video MP3
Similar videos
-
1:06:04
itp: novel treatments
-
33:10
the emerging role of the immune microenvironment in hematological malignancies
-
33:25
novel therapeutic approaches in bpdcn : targeting cd123 and beyond
-
57:12
hsct mobilization strategies in multiple myeloma
-
49:44
tma and stem cell transplantation: from diagnosis to therapy
-
28:15
management of t-all: an update
-
18:58
naval daver - flt3 mutations in aml
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
57:35
dli after allogeneic stem cell transplantation: where do we stand?
-
40:15
cd19 targeted car t cells in refractory systemic lupus erythematosus
-
43:21
treatment options for elderly, but fit patients and the role of nurses
-
34:42
third-party bk virus-specific cytotoxic t lymphocyte therapy for hemorrhagic cystitis...
-
43:40
polatuzumab vedotin in previouslyuntreated diffuse large b-cell lymphoma.
-
38:32
34yo woman with b-all who developed tma after hsct and was treated with a complement inhibitor
-
49:10
car t cell therapy for relapsed lymphoma: journey from being a patient to a survivor
-
58:13
optimising transplant outcome in adults allografted for aml
-
55:02
acute and late toxicities of bi-specific antibody therapy
-
50:51
diagnostic and therapy of ph-like acute lymphoblastic leukemia
-
1:15:58
post-tct review: transplant and cellular therapy (part 1)
-
1:01:10
aplastic anemia management: what's new?